Statin therapy decreases myocardial function as evaluated via strain imaging

Clinical Cardiology

Volumn 32, Issue 12, 2009, Pages 684-689

  Rubinstein, Jack ^a   Aloka, Feras ^a   Abela, George S ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MALE; STRAIN IMAGING; TISSUE DOPPLER IMAGING;

BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART SEPTUM; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MITRAL VALVE; MYOCARDIAL CONTRACTION; SYSTOLE; ULTRASONOGRAPHY, DOPPLER;

EID: 74849093476     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20644     Document Type: Article

References (35)

1. Jukema JW, Bruschke AVG, van Boven AJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: The Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995;91: 2528-2540.
2. Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipidlowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation. 2001;104:387-392.
3. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet. 1996;348(9034):1079-1082.
4. Maycock CAA, Muhlestein JB, Horne BD, et al. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol. 2002;40:1777-1785.
5. The Long-TermIntervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339(19):1349-1357.
6. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensinconverting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291-1295.
7. Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol. 2003;92(12):1379-1383.
8. Reilly SD, Litovsky SH, Steinkampf MP, et al. Statins improve human coronary atherosclerotic plaque morphology. Tex Heart Inst J. 2008;35(2):99-103.
9. Chia S, Raffel OC, Takano M, et al. Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study. Coron Artery Dis. 2008;19(4):237-242.
10. Asbach P, Paetsch I, Stawowy P, et al. Statin-associated focal myositis. Int J Cardiol. 2007;133(1):e33-e34.
11. Needham M, Fabian V, Knezevic W, et al. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007;17(2):194-200.
12. Pasternak RC, Smith SC, Bairey-Merz CN, et al. ACC/AHA/ NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40(3):567-572.
13. Ballantyne CM, Corsini A, Davidson MH, et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003;163:553-564.
14. Antons KA, Williams CD, Baker SK, et al. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med. 2006;119:400-409.
15. Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292:2585-2590.
16. Staffa, JA, Chang, J, Green, L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl JMed. 2002;346:539-540.
17. Baker SK, Tarnopolsky MA. Statin myopathies: pathophysiologic and clinical perspectives. Clin Invest Med. 2001;24(5):258-272.
18. Streb W, Duszánska A, Stabry la-Deska J, et al. The comparison of contrast echocardiography and tissue Doppler imaging for evaluation of reperfused myocardium in patients with acute anterior myocardial infarction. Cardiol J. 2008;15(6):548-554.
19. Marcucci C, Lauer R, Mahajan A. New echocardiographic techniques for evaluating left ventricular myocardial function. Semin Cardiothorac Vasc Anesth. 2008;12(4):228-247.
20. Marsan NA, Westenberg JJ, Tops LF, et al. Comparison between tissue Doppler imaging and velocity-encoded magnetic resonance imaging for measurement of myocardial velocities, assessment of left ventricular dyssynchrony, and estimation of left ventricular filling pressures in patients with ischemic cardiomyopathy. Am J Cardiol. 2008;102(10):1366-1372.
21. St. Vrain J, Bilhorn K, Kurup S, et al. Strain imaging using speckle tracking in the cardiometabolic syndrome: method and utility. J CardioMetabolic Syn. 2008;3(4):258-261.
22. Lin LC,Wu CC, Yeh HI, et al.Downregulatedmyocardial connexin 43 and suppressed contractility in rabbits subjected to a cholesterol-enriched diet. Laboratory Investigation. 2005;85: 1224-1237.
23. Abraham TP, Nishimura RA. Myocardial strain: can we finally measure contractility? J Am Coll Cardiol. 2001;37:731.
24. Mizuguchi Y, Oishi Y, Miyoshi H, et al. Impact of statin therapy on left ventricular function and carotid arterial stiffness in patients with hypercholesterolemia. Circ J. 2008;72(4):538-544.
25. Talini E, Di Bello V, Bianchi C, et al. Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin: a preliminary echocardiographic study. Atherosclerosis. 2008;197(1): 346-354.
26. BountioukosM, Rizzello V, Krenning BJ, et al. Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease. Am J Cardiol. 2003;92(5):613-616.
27. Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 2001;104(3):317-324.
28. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30(2): 474-480.
29. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30(6):1527-1533.
30. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous doppler- catheterization study. Circulation. 2000;102:1788.
31. Draeger A, Monastyrskaya K, Mohaupt M, et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol. 2006;210(1):94-102.
32. Shan K, Bick RJ, Poindexter BJ, et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and betaadrenergic receptor density in humans. J Am Coll Cardiol. 2000; 36(3):891-896.
33. Wang M, Yip GWK, Wang A, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hyperten. 2005;23(1): 183-191.
34. Mulukutla S, Marroquin O, Smith C, et al. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. Am J Cardiol. 2004;94(11): 1363-1366.
35. Okazaki S, Yokoyama T, Miyauchi K, et al. Early statin treatment in patients with acute coronary syndrome. Circulation. 2004;110: 1061-1068.